Collecting images of diseased eyes using the P200TxE device
P200TxE Diseased Eye Image Collection
This study is trying to take detailed pictures of the eyes of people with retinal diseases or glaucoma to help improve understanding and treatment of these conditions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | Optos, PLC Industry-sponsored |
| Locations | 1 site (Louisville, Kentucky) |
| Trial ID | NCT06269666 on ClinicalTrials.gov |
What this trial studies
This study aims to gather images from the P200TxE device specifically in patients with retinal diseases or glaucoma affecting the posterior pole region. Participants will be individuals aged 22 and older who have been diagnosed with relevant ocular conditions. The study will involve capturing high-quality images to enhance understanding and treatment of these eye diseases. The collected data may contribute to future advancements in ophthalmic imaging and patient care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 22 and older diagnosed with retinal pathology or glaucoma affecting the macula or optic nerve.
Not a fit: Patients who cannot tolerate ophthalmic imaging or have unclear ocular media will not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved diagnostic techniques and treatment options for patients with retinal diseases and glaucoma.
How similar studies have performed: While this approach is focused on a specific imaging device, similar studies in ophthalmic imaging have shown promise in enhancing diagnostic capabilities.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female subjects 22 years of age or older who have full legal capacity to subject on the date the informed consent is signed; 2. Subjects who can follow the instructions by the clinical staff at the clinical site; 3. Subjects who agree to participate; 4. Subjects who have been diagnosed with retinal pathology and/or glaucoma that affects the posterior pole region including the macula and/or optic nerve. For glaucoma subjects: a. Glaucoma subjects who have a history of visual field loss and RNFL or optic nerve changes. Exclusion Criteria: 1. Subjects unable to tolerate ophthalmic imaging; 2. Subjects with ocular media not sufficiently clear to obtain acceptable images.
Where this trial is running
Louisville, Kentucky
- Bennett and Bloom Eye Centers — Louisville, Kentucky, United States (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.